Use of selective serotonin reuptake inhibitors and risks of stroke in patients with obsessive compulsive disorder: A population-based study

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Chu, Che Sheng ^a   Chou, Po Han ^a,b,c   Lin, Ching Heng ^a   Cheng, Chin ^d   Tsai, Chia Jui ^a   Lan, Tsuo Hung ^a,b,e   Huang, Min Wei ^a   Nestadt, Gerald ^f  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SERTRALINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; OBSESSIVE COMPULSIVE DISORDER; POPULATION RESEARCH; RETROSPECTIVE STUDY; TAIWAN; YOUNG ADULT; CHEMICALLY INDUCED; COMPLICATION; OBSESSIVE-COMPULSIVE DISORDER; RISK FACTOR;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; RETROSPECTIVE STUDIES; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; STROKE; YOUNG ADULT;

EID: 84990963881     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0162239     Document Type: Article

References (52)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC; 2013.
2. Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psy chiatr Res 2012; 21:169-184. doi: 10.1002/mpr.1359 PMID: 22865617
3. Horwath E, Weissman MM. The epidemiology and cross-national presentation of obsessive-compulsive disorder. Psychiatr Clin North Am 2000; 23:493-507. PMID: 10986723
4. Fontenelle IS, Fontenelle LF, Borges MC, Prazeres AM, Range BP, Mendlowicz MV, et al. Quality of life and symptom dimensions of patients with obsessive-compulsive disorder. Psychiatry Res 2010; 179:198-203. doi: 10.1016/j.psychres.2009.04.005 PMID: 20483484
5. Markarian Y, Larson MJ, Aldea MA, Baldwin SA, Good D, Berkeljon A, et al. Multiple pathways to functional impairment in obsessive-compulsive disorder. Clin Psychol Rev 2010; 30:78-88. doi: 10.1016/j. cpr.2009.09.005 PMID: 19853982
6. Veale D, Roberts A. Obsessive-compulsive disorder. BMJ 2014; 348: g2183. doi: 10.1136/bmj.g2183 PMID: 24709802
7. Stein DJ, Koen N, Fineberg N, Fontenelle LF, Matsunaga H, Osser D, et al. A2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder. Curr Psychiatry Rep 2012; 14: 211-219. doi: 10.1007/s11920-012-0268-9 PMID: 22527872
8. Bak S, Tsiropoulos I, Kjaersgaard JO, Andersen M, Mellerup E, Hallas J, et al. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke 2002; 33:1465-1473. PMID: 12052976
9. Barbui C, Percudani M, Fortino I, Tansella M, Petrovich L. Past use of selective serotonin reuptake inhibitors and the risk of cerebrovascular events in the elderly. Int Clin Psychopharmacol 2005; 20: 169-171. PMID: 15812268
10. Chen Y, Guo JJ, Li H, Wulsin L, Patel NC. Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study. Ann Pharmac-other 2008; 42:177-184. doi: 10.1345/aph.1K369 PMID: 18212255
11. de Abajo FJ, Jick H, Derby L, Jick S, Schmitz S. Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol 2000; 50:43-47. PMID: 10886117
12. Douglas I, Smeeth L, Irvine D. The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study. Br J Clin Pharmacol 2011; 71:116-120. doi: 10.1111/j.1365-2125.2010.03797.x PMID: 21143507
13. Hung CC, Lin CH, Lan TH, Chan CH. The association of selective serotonin reuptake inhibitors use and stroke in geriatric population. Am J Geriatr Psychiatry 2013; 21:811-815. doi: 10.1016/j.jagp.2013.01.018 PMID: 23567390
14. Kharofa J, Sekar P, Haverbusch M, Moomaw C, Flaherty M, Kissela B, et al. Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke 2007; 38:3049-3051. PMID: 17901378
15. Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, Robinson JG, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med 2009; 169:2128-2139. doi: 10.1001/archinternmed.2009.436 PMID: 20008698
16. Swenson JR, Doucette S, Fergusson D. Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials. Can J Psychiatry 2006; 51: 923-929. PMID: 17249635
17. Wu CS, Wang SC, Cheng YC, Gau SS. Association of cerebrovascular events with antidepressant use: a case-crossover study. Am J Psychiatry 2011; 168:511-521. doi: 10.1176/appi.ajp.2010. 10071064 PMID: 21406464
18. Kuo CC, Chien IC, Lin CH, Lee WG, Chou YJ, Lee CH, et al. Prevalence, correlates, and disease patterns of antidepressant use in Taiwan. Compr Psychiatry 2011; 52: 662-669. doi: 10.1016/j.comppsych.2011.01.002 PMID: 21353216
19. Smoller JW Do antidepressants raise the risk of stroke? Am J Psychiatry 2011; 168:457-459. doi: 10.1176/appi.ajp.2011.11020336 PMID: 21536699
20. Jackson CA, Mishra GD. Depression and risk of stroke in midaged women: a prospective longitudinal study. Stroke 2013; 44:1555-1560. doi: 10.1161/STROKEAHA.113.001147 PMID: 23686976
21. Chou PH, Lin CH, Loh el W, Chan CH, Lan TH. Panic disorder and risk of stroke: a population-based study. Psychosomatics 2012; 53: 463-469. doi: 10.1016/j.psym.2012.03.007 PMID: 22902086
22. Merikangas KR, Fenton BT, Cheng SH, Stolar MJ, Risch N. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 1997; 54:362-368. PMID: 9109736
23. Chen SJ, Chao YL, Chen CY, Chang CM, Wu EC, Wu CS, et al. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br J Psychiatry 2012; 200:374-380. doi: 10.1192/bjp.bp.111.092098 PMID: 22442099
24. Chien IC, Bih SH, Chou YJ, Lin CH, Lee WG, Chou P. Trends in the use of psychotropic drugs in Taiwan: a population-based national health insurance study, 1997-2004. Psychiatr Serv 2007; 58:554-557. PMID: 17412860
25. Chou PH, Lin CH, Cheng C, Chang CL, Tsai CJ, Tsai CP, et al. Risk of depressive disorders in women undergoing hysterectomy: A population-based follow-up study. J Psychiatr Res 2015; 68:186-191. doi: 10.1016/j.jpsychires.2015.06.017 PMID: 26228418
26. Chou PH, Lin CC, Lin CH, Tsai CJ, Cheng C, Chuo YP, et al. Prevalence of gastroesophageal reflux disease in major depressive disorder: a population-based study. Psychosomatics 2014; 55:155-162.
27. Chou PH, Chu CS, Lin CH, Cheng C, Chen YH, Lan TH, et al. Use of atypical antipsychotics and risks of cataract development in patients with schizophrenia: A population-based, nested case-control study. Schizophr Res 2016; 174:137-143. doi: 10.1016/j.schres.2016.03.027 PMID: 27061658
28. Chou PH, Lin CC, Lin CH, Loh el W, Chan CH, Lan TH. Prevalence of allergic rhinitis in patients with attention-deficit/hyperactivity disorder: a population-based study. Eur Child Adolesc Psychiatry 2013; 22: 301-307. doi: 10.1007/s00787-012-0369-3 PMID: 23274480
29. Drummond LM, Boschen MJ, Cullimore J, Khan-Hameed A, White S, Ion R. Physical complications of severe, chronic obsessive-compulsive disorder: a comparison with general psychiatric inpatients. Gen Hosp Psychiatry 2012; 34:618-625. doi: 10.1016/j.genhosppsych.2012.02.001 PMID: 22459999
30. Albert U, Aguglia A, Chiarle A, Bogetto F, Maina G. Metabolic syndrome and obsessive-compulsive disorder: a naturalistic Italian study. Gen Hosp Psychiatry 2013; 35:154-159. doi: 10.1016/j. genhosppsych.2012.10.004 PMID: 23158675
31. Tsukamoto Y, Takahashi W, Takizawa S, Kawada S, Takagi S. Chronic kidney disease in patients with ischemic stroke. J Stroke Cerebrovasc Dis 2012; 21: 547-550. doi: 10.1016/j.jstrokecerebrovasdis.2010.12.005 PMID: 21295995
32. Koren-Morag N, Goldbourt U, Tanne D. Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology 2006; 67:224-228. PMID: 16864812
33. Endres M, Heuschmann PU, Laufs U, Hakim AM. Primary prevention of stroke: blood pressure, lipids, and heartfailure. Eur Heart J 2011; 32:545-552. doi: 10.1093/eurheartj/ehq472 PMID: 21285072
34. Farooqui AA, Farooqui T, Panza F, Frisardi V. Metabolic syndrome as a risk factor for neurological disorders. Cell Mol Life Sci 2012; 69: 741-762. doi: 10.1007/s00018-011-0840-1 PMID: 21997383
35. Salminen M, Kuoppamaki M, Vahlberg T, Raiha I, Irjala K, Kivela SL. Metabolic syndrome and vascular risk: a 9-year follow-up among the aged in Finland. Acta Diabetol 2011; 48:157-165. doi: 10.1007/ s00592-010-0251-z PMID: 21234614
36. Bloch MH, Mc Guire J, Landeros-Weisenberger A, Leckman JF, Pittenger C. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry 2010; 15: 850-855. doi: 10.1038/mp.2009.50 PMID: 19468281
37. Bollini P, Pampallona S, Tibaldi G, Kupelnick B, Munizza C. Effectiveness of antidepressants. Metaanalysis of dose-effect relationships in randomised clinical trials. Br J Psychiatry 1999; 174:297-303. PMID: 10533547
38. Skop BP, Brown TM. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 1996; 37:12-16. PMID: 8600488
39. Li N, Wallen NH, Ladjevardi M, Hjemdahl P. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis 1997; 8:517-523. PMID: 9491270
40. van Zwieten PA. Pathophysiological relevance of serotonin. J Cardiovasc Pharmacol 10 1987; Suppl 3:: S19-25. PMID: 2446063
41. Wgner A, Montero D, Martensson B, Siwers B, Asberg M. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder. J Affect Disord 1990; 20:101-113. PMID: 2176228
42. Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther 2000; 68:435-442. PMID: 11061584
43. Bismuth-Evenzal Y, Gonopolsky Y, Gurwitz D, Iancu I, Weizman A, Rehavi M. Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs. J Affect Disord 2012; 136: 99-103. doi: 10.1016/j.jad.2011.08.013 PMID: 21893349
44. Galan AM, Lopez-Vilchez I, Diaz-Ricart M, Navalon F, Gomez E, Gasto C, et al. Serotonergic mechanisms enhance platelet-mediated thrombogenicity. Thromb Haemost 2009; 102:511-519. doi: 10. 1160/TH08-12-0810 PMID: 19718472
45. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 2001; 104:1894-1898. PMID: 11602490
46. Schlienger RG, Fischer LM, Jick H, Meier CR. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Saf 2004; 27:1157-1165. PMID: 15554748
47. Mortensen JK, Larsson H, Johnsen SP, Andersen G. Impact of prestroke selective serotonin reuptake inhibitor treatment on stroke severity and mortality. Stroke 2014; 45:2121-2123. doi: 10.1161/ STROKEAHA.114.005302 PMID: 24893612
48. Hackam DG, Mrkobrada M. Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis. Neurology 2012; 79:1862-1865. doi: 10.1212/WNL0b013e318271f848 PMID: 23077009
49. Luitse MJ, Biessels GJ, Rutten GE, Kappelle LJ. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol 2012; 11: 261-271. doi: 10.1016/S1474-4422(12)70005-4 PMID: 22341034
50. Eaton WW, Roth KB, Bruce M, Cottler L, Wu L, Nestadt G, et al. The relationship of mental and behavioral disorders to all-cause mortality in a 27-year follow-up of 4 epidemiologic catchment area samples. Am J Epidemiol 2013; 178:1366-1377. doi: 10.1093/aje/kwt219 PMID: 24091891
51. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011; 20:236-242. doi: 10.1002/pds.2087 PMID: 21351304
52. Roumie CL, Mitchel E, Gideon PS, Varas-Lorenzo C, Castellsague J, Griffin MR. Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiol Drug Saf 2008; 17:20-26. PMID: 17979142